Waiting time for surgery and health-related quality of life in patients with inflammatory bowel disease.
6 affiliations
- 1Department of Surgery, IBD-SURG-Inflammatory Bowel Disease Surgical Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. [email protected].
- 2Department of Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden. [email protected].
- 3Department of Surgery, IBD-SURG-Inflammatory Bowel Disease Surgical Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- 4Department of Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
- 5Gothia Forum for Clinical Trials, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- 6Department of Surgery, SSORG-Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Abstract
Purpose
When surgery is indicated in patients with inflammatory bowel disease (IBD), timely intervention may reduce the risk of further complications. This study aimed to assess health-related quality of life (HRQoL) in relation to waiting time for IBD surgery.Methods
This cross-sectional, register-based study assessed HRQoL using the EQ-5D-5L questionnaire. Patients with IBD who had undergone surgery or were awaiting surgery between 2017 and 2023 at Sahlgrenska University Hospital, Gothenburg, Sweden, were identified and invited to participate.Results
A total of 214 patients were included in the study (33.6% women, mean age 44.3 ± 16.9 years). Sixty percent had undergone surgery, while the remainder were awaiting surgery. The mean EQ VAS was 64.9, and the lowest scores were observed in patients waiting for surgery for over a year, compared to Swedish age-matched population norms, with a mean EQ VAS of 87.0. Using the Swedish value set, the mean EQ-5D-5L index was higher among patients waiting for surgery < 3 months compared with those waiting 12-24 months (p = 0.017) and > 24 months (p = 0.012). It was also higher among patients waiting 3-6 months compared with those waiting 12-24 months (p = 0.036) and > 24 months (p = 0.032).Conclusion
Prolonged waiting time for IBD surgery was associated with impaired HRQoL, particularly among patients who had waited more than 1 year. While causal inferences cannot be drawn from this cross-sectional study, the findings support incorporating patient-reported HRQoL into prioritisation of patients awaiting IBD surgery.Trial registration
The study has been registered in clinicaltrials.gov (NCT: 2022-05975-01).
Related
- Evolution of temporomandibular joint-related clinical findings and patient reported quality of life after orthognathic surgery: a prospective multicenter study
- Associations between redox-related biomarkers and treatment response in patients with inflammatory bowel disease initiating infliximab or vedolizumab
- Immune checkpoint inhibitors and the inflammatory dysregulation: decoding cutaneous and gastrointestinal immune-related adverse events for the allergist and immunologist
- Robotic surgery in inflammatory bowel disease: a systematic review.
- Cytokine profiles of aqueous humor from sequential bilateral cataract surgery: Impact of diabetes on inflammatory responses
BibTeX
@article{croix2026waiting,
title = {{Waiting time for surgery and health-related quality of life in patients with inflammatory bowel disease.}},
author = {Hanna de la Croix and Helena Åberg and Stephanie Fledsberg and Jennifer Park and Jonas Bengtsson and Maria Hermanson},
journal = {International journal of colorectal disease},
year = {2026},
month = oct,
doi = {10.1007/s00384-026-05258-9},
url = {https://europepmc.org/article/MED/42909622},
note = {CC BY},
}
RIS
TY - JOUR
TI - Waiting time for surgery and health-related quality of life in patients with inflammatory bowel disease.
AU - Hanna de la Croix
AU - Helena Åberg
AU - Stephanie Fledsberg
AU - Jennifer Park
AU - Jonas Bengtsson
AU - Maria Hermanson
PY - 2026
DA - 2026/10/23
JO - International journal of colorectal disease
DO - 10.1007/s00384-026-05258-9
UR - https://europepmc.org/article/MED/42909622
AB - Purpose When surgery is indicated in patients with inflammatory bowel disease (IBD), timely intervention may reduce the risk of further complications. This study aimed to assess health-related quality of life (HRQoL) in relation to waiting time for IBD surgery.Methods This cross-sectional, register-based study assessed HRQoL using the EQ-5D-5L questionnaire. Patients with IBD who had undergone surgery or were awaiting surgery between 2017 and 2023 at Sahlgrenska University Hospital, Gothenburg, Sweden, were identified and invited to participate.Results A total of 214 patients were included in the study (33.6% women, mean age 44.3 ± 16.9 years). Sixty percent had undergone surgery, while the remainder were awaiting surgery. The mean EQ VAS was 64.9, and the lowest scores were observed in patients waiting for surgery for over a year, compared to Swedish age-matched population norms, with a mean EQ VAS of 87.0. Using the Swedish value set, the mean EQ-5D-5L index was higher among patients waiting for surgery < 3 months compared with those waiting 12-24 months (p = 0.017) and > 24 months (p = 0.012). It was also higher among patients waiting 3-6 months compared with those waiting 12-24 months (p = 0.036) and > 24 months (p = 0.032).Conclusion Prolonged waiting time for IBD surgery was associated with impaired HRQoL, particularly among patients who had waited more than 1 year. While causal inferences cannot be drawn from this cross-sectional study, the findings support incorporating patient-reported HRQoL into prioritisation of patients awaiting IBD surgery.Trial registration The study has been registered in clinicaltrials.gov (NCT: 2022-05975-01).
SN - 0179-1958
SN - 1432-1262
ER -